Stock listing
Gelteq Limited
Selected listing: GELS · NASDAQ · USD · US
Gelteq Limited (NASDAQ:GELS), Health Technology. Latest release Jun 17, 2026: Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical…
- Ticker
- NASDAQ:GELS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Gelteq Limited
Gelteq Limited, trading under the ticker GELS, is a public company based in the American market. Gelteq focuses on developing innovative solutions in its industry, aiming to enhance operational efficiency and drive growth.
Latest news from Gelteq Limited
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs
June 17, 2026
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications
June 11, 2026
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion
June 3, 2026
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
May 20, 2026
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth
May 12, 2026